Lexicon Pharmaceuticals Eulerpool News

Lexicon Pharmaceuticals Eulerpool News

Lexicon Pharmaceuticals Stock News

Lexicon Pharmaceuticals is being monitored by journalists and investors worldwide. We gather the latest Lexicon Pharmaceuticals news here.

• June 21 ·

  Yahoo
  Sector Update: Health Care Stocks Gain in Late Afternoon
• June 21 ·

  Yahoo
  Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes
• June 21 ·

  Seeking Alpha
  Lexicon resubmits FDA application for sotagliflozin for type 1 diabetes
• June 21 ·

  TipRanks
  Buy Rating on Lexicon Pharmaceuticals Amid Strong Prospects for Sotagliflozin’s FDA Approval
• June 21 ·

  Thefly.com
  Lexicon resubmits sotagliflozin NDA for Type 1 Diabetes
• June 19 ·

  Yahoo
  Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association
• June 19 ·

  Thefly.com
  Lexicon reports paper on Phase 2 RELIEF-DPN-1 trial published
• June 18 ·

  Yahoo
  Analysis of INPEFA® (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of Cardiology
• June 18 ·

  Thefly.com
  Lexicon announces publication on cost-effectiveness of INPEFA
• June 17 ·

  Benzinga
  Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session